Research Western
Funding Opportunites - Research
Further details regarding this announcement can be found at:
https://www.alzdiscovery.org/research-and-grants/funding-opportunities
Sponsor/Award: ALZHEIMER'S DRUG DISCOVERY FOUNDATION - CORE FUNDING PROGRAMS - 2020 SPRING COMPETITION | LETTER OF INTENT

Grant Amount: VARIED
Deadline: Dean's: Contact your Faculty Research Office for deadline details.
Internal: May 13, 2022
Sponsor's: May 20, 2022

Subject Areas: Cognitive Development or Processes, Alzheimer's Disease
Description:

The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias.

For Core RFPs, applicants are invited to resubmit proposals up to two times if they are able to address the reviewers' concerns. Resubmissions should include a point-by-point response to the review critiques.

Application Details:

A Letter of Intent (LOI) is required to determine the ADDF's interest prior to a full application. If the submitted Letter of Intent is not consistent with our mission, a full proposal will not be invited. Letters of Intent to the General RFP are accepted throughout the year. Review cycles are held quarterly.

Only those who have completed a successful Letter of Intent will be invited to submit a Full Proposal

INDIRECT COSTS ARE NOT SUPPORTED BY THIS PROGRAM.

NOTE: All Letters of Intent and Full Applications must be processed through Research Development & Services for institutional approval. Requests for Institutional approvals should be received no less than 3 days prior to the posted Sponsor deadline. A ROLA Proposal (bearing applicant, Chair and Dean electronic approvals) is required for each submission.
Western Contacts: Latinovich,Cessandra
Kilianski,Louise
Hancock,Jennifer Anne
Patel,Pinal

Sponsor Contacts:

GRANTS@ALZDISCOVERY.ORG
1414 Avenue of the Americas
Suite 1502
New York, New York, United States